Bolt Biotherapeutics, Inc.
BOLT • NASDAQ
Bolt Biotherapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO William Quinn, with a market cap of $8.4M.
CEOWilliam Quinn
Next Earnings
Upcoming earnings announcement for Bolt Biotherapeutics, Inc.
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$3.69
Revenue Estimate
$1.5M
Earnings History
Past 12 earnings reports for Bolt Biotherapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | -$3.84Est: -$5.02 | +23.5% | $2.5MEst: $914.4K | +173.4% |  10-K |
| Nov 12, 2025 | Q3 2025 | -$3.72Est: -$5.26 | +29.3% | $2.2MEst: $712.5K | +204.4% | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$4.46Est: -$6.32 | +29.4% | $1.8MEst: $907.9K | +98.7% | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.29Est: -$0.32 | +9.4% | $1.2MEst: $1.0M | +19.8% | 10-Q |
| Mar 24, 2025 | Q4 2024 | -$0.38Est: -$0.38 | 0.0% | -Est: $790.0K | -100.0% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.40Est: -$0.35 | -14.3% | $1.1MEst: $1.3M | -9.4% | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.56Est: -$0.48 | -16.7% | $1.3MEst: $891.5K | +43.0% | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.28Est: -$0.51 | +45.1% | $5.3MEst: $2.1M | +156.0% | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.47Est: -$0.48 | +2.1% | $2.1MEst: $1.7M | +22.2% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.43Est: -$0.50 | +14.0% | $2.5MEst: $1.7M | +47.0% | — |
| Aug 7, 2023 | Q2 2023 | -$0.48Est: -$0.49 | +2.0% | $1.4MEst: $1.9M | -24.6% | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.45Est: -$0.51 | +11.8% | $1.8MEst: $1.3M | +39.4% | — |